DPH Communicable Diseases Memos
DPH periodically publishes numbered memos to update providers and interested parties of important information. See our COVID-19 webpages.
| Memo Number | Description | Issue Date | Attachments | Obsolete date |
|---|---|---|---|---|
|
BCD 2024-02 |
Influenza Testing and Variant Influenza A Virus Detection | |||
|
BCD 2024-01 |
Invasive Cronobacter Infection Among Infants is Now a Reportable Condition in Wisconsin | |||
|
BCD 2023-06 |
Rising Congenital Syphilis Cases: Test for Syphilis During Pregnancy | |||
|
BCD 2023-05 |
Changes to COVID-19 Reporting Requirements in Wisconsin | |||
|
BCD 2023-04 |
Respiratory Syncytial Virus (RSV)-Associated Hospitalizations and RSV-Associated Pediatric Deaths are Now Reportable Conditions in Wisconsin | |||
|
BCD 2023-03 |
Vancomycin-Intermediate Staphylococcus aureus (VISA) and Vancomycin-Resistant Staphylococcus aureus (VRSA) as Reportable Conditions in Wisconsin | |||
|
BCD 2023-02 |
Clinical and Laboratory Guidance for Suspected Treatment Failure Among Patients Treated for Gonorrhea Infection | |||
|
BCD 2023-01 Replaced by Influenza Testing and Variant Influenza A Virus Detection |
Influenza Testing and Variant Influenza A Virus Detection | |||
|
BCD 2022-13a |
Recommendations for COVID-19 Prevention and Mitigation Among Migrant and Seasonal Agricultural Workers (En Espanol) | |||
|
BCD 2022-13 |
Recommendations for COVID-19 Prevention and Mitigation Among Migrant and Seasonal Agricultural Workers | |||
|
BCD 2022-12 Replaced by Influenza Testing and Variant Influenza A Virus Detection |
Influenza Testing and Variant Influenza A Virus Detection | |||
|
BCD 2022-11 |
At-Home COVID-19 Antigen Testing Use and Reporting | |||
|
BCD 2022-10 |
COVID-19 Vaccination for Wisconsin’s Youngest Children - To Pharmacists | |||
|
BCD 2022-09 |
COVID-19 Vaccination for Wisconsin’s Youngest Children - To Pediatricians | |||
|
BCD 2022-08a: Replaced by Recommendations for COVID-19 Prevention and Mitigation Among Migrant and Seasonal Agricultural Workers (En Espanol) |
Recommendations for COVID-19 Prevention and Mitigation Among Migrant and Seasonal Agricultural Workers (En Espanol) | |||
|
BCD 2022-08: Replaced by Recommendations for COVID-19 Prevention and Mitigation Among Migrant and Seasonal Agricultural Workers |
Recommendations for COVID-19 Prevention and Mitigation Among Migrant and Seasonal Agricultural Workers | |||
|
BCD 2022-07 |
COVID-19 Oral Antivirals Medications for Long-Term Care Residents | |||
|
BCD 2022-06 |
Surveillance for Carbapenemase-Producing Carbapenem-Resistant Acinetobacter baumannii (CP-CRAB), Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa (CP-CRPA), and Candida auris | |||
|
BCD 2022-05 |
Carbapenem-Resistant Enterobacterales (CRE) as a Reportable Condition in Wisconsin | |||
|
BCD 2022-04 BCD 2023-05 |
Updated SARS-CoV-2 Laboratory Data Reporting Guidance Effective April 4, 2022 | |||
|
BCD 2022-03 |
Reporting of Treponemal and Non-Treponemal Syphilis Testing and the Correct Syphilis Testing Algorithm for CDC Defined Reverse Sequence Syphilis Testing | |||
|
BCD 2022-02 |
Standing Order for Distribution of COVID-19 At-Home Antigen Test Kits | |||
|
BCD 2022-01 |
Prioritization of Highest Impact Public Health Response Activities | |||
|
BCD 2021-13: Replaced by Preventing and Controlling Respiratory Illness Outbreaks in Long-Term Care Facilities |
Prevention and Control of Acute Respiratory Illness Outbreaks in Long-Term Care Facilities | |||
|
BCD 2021-12 |
Public Health Advisory: Anticipated Surge in COVID-19 Disease Activity due to Omicron Variant | |||
|
BCD 2021-11: Memo replaced by Preventing and Controlling Respiratory Illness Outbreaks in Long-Term Care Facilities |
Prevention and Control of Acute Respiratory Illness Outbreaks in Long-Term Care Facilities | |||
|
BCD 2021-10 |
Considerations for Confirmatory Testing of COVID-19 Point-of-Care Tests | |||
|
BCD 2021-09 |
Increased Incidence of Multi-System Inflammatory Syndrome in Children | |||
|
BCD 2021-08 |
Standing Prescription Order for COVID-19 Vaccines | |||
|
BCD 2021-07 |
Revised COVID-19 Monoclonal Antibody Ordering Process | |||
|
BCD 2021-06 |
DHS Requests Nursing Homes Join Hospitals in Wisconsin to Use the EMResource Bed Tracking System for Health Care Entities | |||
|
BCD 2021-05: Replaced by Legionellosis (Legionnaires' Disease and Pontiac Fever) webpage Legionellosis (Legionnaires' Disease and Pontiac Fever) |
Increased Reports of Laboratory-Confirmed Cases of Legionellosis (Legionnaires’ Disease) | |||
|
BCD-2021-04 |
Increased Reports of Laboratory-Confirmed Cases of Cyclosporiasis | |||
|
BCD-2021-03: Memo replaced by At-Home COVID-19 Antigen Testing Use and Reporting |
Public Health Reporting Requirements for At-Home COVID-19 Tests | |||
|
BCD 2021-02 |
Influenza Testing and Variant Influenza A Virus Detection | |||
|
BCD-2021-01 |
COVID-19 Antigen Testing: Reporting Guidance for Employers | |||
|
BCD 2020-29 |
DHS recommends testing migrant and seasonal workers for COVID-19 prior to departure at the end of the work season | |||
|
BCD 2020-28 |
Guidance Related to Viral Whole Genome Sequencing of SARS-CoV-2 for the Public Health Response | |||
|
BCD 2020-27: Memo replaced by Preventing and Controlling Respiratory Illness Outbreaks in Long-Term Care Facilities |
Prevention and Control of Acute Respiratory Illness Outbreaks in Long-Term Care Facilities | |||
|
BCD-2020-26: Memo replaced by BCD 2021-011 |
Prevention and Control of Acute Respiratory Illness Outbreaks in Long-Term Care Facilities | |||
|
BCD 2020-25 |
Crisis Standards of Practice for COVID-19 Contact Tracing and Symptom Monitoring | |||
|
BCD 2020-24 |
Ryan White Part B and Life Care Services Policy: Requesting an Increase in Funding for Ryan White Services | |||
|
BCD 2020-23 |
Bordetella parapertussis Reporting | |||
|
BCD 2020-22 |
Ryan White Part B and Life Care Services Emergency Financial Assistance Policy in Response to COVID-19: Funding Extension | |||
|
BCD 2020-21 |
Guidance on the disposition of medically stable post-acute and long-term care residents with confirmed or clinically suspected COVID-19 infection | |||
|
BCD 2020-20 |
Guidance on the Transfer of Hospitalized Patients Infected with COVID-19 to Post-Acute and Long-Term Care Facilities | |||
|
BCD 2020-19 |
Guidance on the Role of COVID-19 Testing in Decisions Around Transfers From Acute Care Hospitals to Post-Acute and Long-Term Care Facilities | |||
|
BCD 2020-18 |
Guidance to Coroners and Medical Examiners on Postmortem COVID-19 Testing at the Wisconsin State Laboratory of Hygiene and the Milwaukee Health Department Laboratory | |||
|
BCD 2020-17: Memo replaced by BCD 2023-05 |
Changes to COVID-19 Reporting Requirements for Wisconsin Hospitals and Health Departments | |||
|
BCD 2020-16 |
Important Guidance for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) (REVISED) in Long-Term Care Facilities and Assisted Living Facilities |